Regulation of AMPA-type glutamate receptor number at synapses underlies modulation of synaptic strength during homeostatic scaling. Wang et al. show that the secreted protein semaphorin 3F (Sema3F) and its neuropilin-2/plexinA3 holoreceptor mediate homeostatic plasticity in cortical neurons.
Correspondence kolodkin@jhmi.edu
In Brief
Regulation of AMPA-type glutamate receptor number at synapses underlies modulation of synaptic strength during homeostatic scaling. Wang et al. show that the secreted protein semaphorin 3F (Sema3F) and its neuropilin-2/plexinA3 holoreceptor mediate homeostatic plasticity in cortical neurons.
INTRODUCTION
Hebbian plasticity mechanisms, including long-term potentiation (LTP) and long-term depression (LTD), underlie many forms of learning and memory. If unchecked, LTP and LTD can disrupt neuronal network function (Abbott and Nelson, 2000; Miller and Mackay, 1994) ; however, homeostatic plasticity mechanisms allow neural circuits to cope with these destabilizing forces. In the central nervous system (CNS), neurons can maintain their firing rates through homeostatic scaling (Turrigiano, 2012) . Homeostatic scaling was initially characterized in cultured neurons by the observation that long-term pharmacological disruption of neuronal activity leads to bidirectional adjustment of synaptic strength (O'Brien et al., 1998; Turrigiano et al., 1998) . Homeostatic scaling can change synaptic strength globally in a given neuron, or locally at individual synapses, maintaining the relative weight of different synaptic inputs and allowing neurons to maintain balanced, optimized firing rates while preserving the relative strengths of synaptic connections (Turrigiano, 2012) .
Blocking neuronal activity in vitro using tetrodotoxin (TTX) leads to increased synaptic strength, or upscaling, whereas elevating neuronal activity with bicuculline leads to decreased synaptic strength, or downscaling. Synaptic scaling is also observed in vivo (Desai et al., 2002; Hengen et al., 2016; Lee and Whitt, 2015) . A wide range of intracellular and extracellular molecules and signaling pathways regulate homeostatic scaling. For example, brain-derived neurotrophic factor (BDNF) is important for homeostatic upscaling; BDNF depletion resembles TTX-induced mEPSC amplitude upscaling. Additional factors that mediate upscaling include tumor necrosis factor alpha (TNFa), the C-kinase 1-interacting protein PICK1 and the glutamate receptor interacting protein GRIP1, and the immediate early gene Arc (Gainey et al., 2015; Tan et al., 2015; Turrigiano, 2012; Wang et al., 2012a) . Further, homer1a and Eph4A receptor tyrosine kinase are important for neuronal activity-induced synaptic downscaling (Turrigiano, 2012) . Synaptic upscaling and downscaling can also utilize the same molecules and signaling pathways, including N-cadherin/ b-catenin-mediated cell adhesion, calcium signaling through calcium/calmodulin-dependent protein kinases (CaMKs), and also GluA1 phosphorylation by protein kinase A (Diering et al., 2014; Okuda et al., 2007; Vitureira et al., 2011) .
Modulation of synaptic strength is largely dependent on postsynaptic neurotransmitter receptor distribution and function, and homeostatic scaling can involve regulation of AMPARs through several mechanisms (Huganir and Nicoll, 2013; O'Brien et al., 1998; Turrigiano, 2012) . Transmembrane AMPAR regulatory proteins (TARPs), along with other auxiliary subunits, serve to regulate synaptic AMPAR synaptic targeting, channel conductance, and other aspects of receptor properties (Jackson and Nicoll, 2011) . Several complement C1r/c1s, Uegf, Bmp1 (CUB) domain-containing transmembrane proteins, including SOL-1, SOL-2, and LEV-10 in C. elegans, Neto in Drosophila, and Neto1 and Neto2 in rodents, interact with a variety of neurotransmitter receptors to regulate their trafficking and function (Greger et al., 2017; Howe, 2015; Jackson and Nicoll, 2011; Straub and Tomita, 2012; Vernon and Swanson, 2017; Wang et al., 2012a) . It remains to be determined whether any of these CUB domain proteins are themselves regulated by extracellular signals.
Semaphorin proteins (Semas) were initially characterized as repulsive and attractive neuronal guidance cues during neural development (Tran et al., 2007) . Plexins, a large family of conserved transmembrane receptors, are the major signaling receptors that mediate Sema functions (Pasterkamp, 2012) . Most vertebrate-secreted Semas do not bind directly to plexins; instead, they associate with a neuropilin (Npn) co-receptor, a transmembrane protein that together with an A class plexin receptor constitute secreted Sema holoreceptors. For example, during neural development the secreted semaphorin Sema3F signals repulsive guidance events critical for axon patterning through a holoreceptor complex comprised of Npn-2 and PlexA3 (Tran et al., 2007) .
Semaphorins also function later in mammalian neural development to regulate the elaboration of dendritic morphology, excitatory and inhibitory synaptogenesis, and synapse function (Koropouli and Kolodkin, 2014) . Sema3F constrains dendritic spine number on apical dendrites of cortical pyramidal neurons and also regulates excitatory synapse formation and function in these same neurons. Further, Sema3F modulates synaptic transmission in hippocampal dentate granule and CA1 neurons, and the Sema3F co-receptor Npn-2 is enriched in postsynaptic density (PSD) fractions from adult mouse forebrain. Additionally, the related secreted semaphorin Sema3A modulates excitatory synaptic transmission in hippocampal neurons in vitro, class 5 transmembrane Semas negatively regulate dendritic spine development and synaptogenesis in hippocampal dentate granule cells, and class 4 Semas influence both inhibitory and excitatory synaptogenesis (Koropouli and Kolodkin, 2014) . The expression of Semas and their receptors in the adult nervous system (Duan et al., 2014; Sahay et al., 2005) raises the possibility that they may also impact synaptic function and plasticity at mature synapses.
Here, we investigate the role of Sema signaling in homeostatic synaptic plasticity, focusing on the regulation of cell surface glutamate receptor levels following changes in neural activity. We find that Sema3F and its Npn-2/PlexA3 receptor complex are required for activity-dependent modulation of cell surface AMPAR levels, revealing a novel role for secreted semaphorins and their receptors in homeostatic synaptic plasticity in response to changes in neural activity.
RESULTS

Sema3F Is Expressed in Cortical Neurons and Its Secretion Is Regulated by Neuronal Activity
To address how classical guidance cues influence neural plasticity, we sought to refine our understanding of Sema3F function at mature synapses. To better define Sema3F expression in the adult nervous system, we generated an N-terminally tagged Sema3F knockin mouse ( Myc Sema3F) in which a 6xMyc epitope coding sequence was inserted in the endogenous Sema3F locus downstream of the Sema3F signal sequence ( Figure S1 ). Myc Sema3F homozygous mice show none of the neural developmental phenotypes associated with Sema3F null mutants (data not shown). A Myc antibody was used for western blot analysis to detect Myc Sema3F in neocortical brain lysates derived from Myc/Myc Sema3F mice at various developmental stages, from embryonic day 14.5 (E14.5) to postnatal day 42 (P42). We observed one major band at the predicted molecular weight of Sema3F, along with several minor bands that are most likely the result of proteolytic processing (Adams et al., 1997 ) ( Figure 1A ). Myc Sema3F protein expression is highest in the embryonic and early postnatal neocortex, gradually declining after birth but remaining expressed in the adult neocortex, like its Npn-2 receptor ( Figure 1A) . We next performed immunohistochemistry on sections obtained from adult
Myc/Myc
Sema3F mice, staining with a Myc antibody and co-staining with antibodies directed against Ctip2 (a deep layer cortical neuron marker; Arlotta et al., 2005) and CaMKII (Ca 2+ /calmodulin-dependent protein kinase II, a marker for excitatory neurons; Kennedy et al., 1983 , neocortex (Tran et al., 2009 ). We observed a significant increase in AP-Npn-2
Ecto binding following bicuculline treatment, but not TTX treatment ( Figures  1E and 1F ), similar to our observations of Myc Sema3F protein levels in Myc Sema3F neuronal cultures. To address the possibility that bicuculline non-specifically increases global neuronal secretion, we used an AP-conjugated Npn-1 extracellular domain (AP-Npn-1 Ecto ) to detect the secreted semaphorin Sema3A and observed Sema3A expression in cortical neuron culture medium ( Figures 1E and 1F ). However, neither bicuculline nor TTX altered Sema3A levels. These results suggest that increased neuronal activity selectively promotes Sema3F secretion.
Sema3F -/-Cortical Neurons Display a Deficit in Cell
Surface AMPA Receptor Downscaling The regulation of Sema3F secretion by prolonged changes in neuronal activity raises the possibility that Sema3F participates in activity-induced synaptic plasticity. To investigate the role of Sema3F signaling in homeostatic scaling, we first compared GluA1 cell surface expression levels in Sema3F À/À and wildtype cultured cortical neurons. Cell surface proteins were biotinylated and GluA1 was detected by western blot analysis, in addition to live staining, to assess cell surface GluA1 levels (neurons were cultured from E14.5 mouse cortices for 14 DIV). We did not observe significant differences in cell surface GluA1 levels between wild-type and Sema3F À/À cultures (Figures 2A and 2C) . We next examined GluA1 cell surface levels following treatment with either bicuculline or TTX for 48 hr, which induces either down-or upscaling, respectively, that is reflected by changes in cell surface AMPA receptor expression (O'Brien et al., 1998; Turrigiano et al., 1998) . Treatment with bicuculline results in a reduction in cell surface GluA1 in wildtype cortical neurons, here detected by an antibody against the extracellular region of GluA1 in living cultures (Figures 2A and 2B) and also by cell surface biotinylation and subsequent western analysis ( Figures 2C and 2D ). However, bicuculline treatment of Sema3F À/À cortical cultures does not result in a significant change in cell surface GluA1 expression ( Figures  2A-2D ). Upon TTX or bicuculline treatment, previous studies report changes in surface AMPAR abundance that include both GluA1 and GluA2 AMPAR subunits (Cingolani et al., 2008; Diering et al., 2014; O'Brien et al., 1998; Wierenga et al., 2005) . We investigated cell surface GluA2 scaling in 
Myc
Sema3F knockin cortical neuron cultures (from E14.5 mouse embryos cultured 14 DIV) treated with bicuculline (Bic 40 mM), tetrodotoxin (TTX 1 mM) or control media (Con) for 48 hr were immunoblotted using a Myc antibody. Cell lysates derived from the same cortical cultures from which supernatants were obtained were immunoblotted with both Myc and b-tubulin antibodies. (D) Quantification of Myc Sema3F expression levels from samples shown in (C) (n = 3 experiments). For quantification, the intensity of supernatant Myc Sema3F western bands was normalized to the intensity of Myc Sema3F observed in cortical culture lysates; the value of normalized control samples (Con) was set at 100%.
(E) Supernatants obtained from wild-type cortical cultures were blotted onto nitrocellulose membranes and incubated with either AP-Npn-2 Ecto or AP-Npn-1 Ecto (5 nM) to probe for the presence of Sema3F or Sema3A, respectively. (F) Quantification of experiments in (E) (n = 3 experiments). *p < 0.05; ns, not significant. Statistical comparisons performed using one-way ANOVA with Bonferroni multiple comparisons test. Error bars represent standard error of the mean (SEM). Scale bar, 20 mm. See related Figure S1 .
wild-type and Sema3F À/À cultures and observed results similar to GluA1 ( Figures 2C and 2D ). Importantly, TTX treatment results in an increase in cell surface GluA1 both in wild-type and Sema3F À/À cortical cultures, showing that Sema3F is required for bicuculline-induced downscaling but not TTXinduced upscaling of cell surface AMPA receptors.
To assess direct effects of Sema3F on cell surface GluA1 levels, we treated cultured cortical neurons with Sema3F for various times and measured GluA1 cell surface expression. Treatment with Sema3F for 48 hr leads to a significant reduction in neuronal cell surface GluA1 levels ( Figures 2E and 2F) , and when cultured neurons were treated with both bicuculline and Sema3F together no further reduction in cell surface GluA1 was observed beyond that resulting from treatment with bicuculline alone ( Figures 2G and 2H ). These results suggest that Sema3F and bicuculline act in the same AMPAR cell surface downscaling signaling pathway.
Neuropilin-2 Is Expressed at Synapses and Is Required for Bicuculline-Induced Cell Surface AMPAR Downscaling Neuropilin-2 (Npn-2), an obligate co-receptor component of the Sema3F holoreceptor, is expressed in the murine adult brain and is also enriched in PSD fractions (Sahay et al., 2005) . To further investigate Npn-2 subcellular localization, we generated an N-terminally hemagglutinin (HA)-tagged Npn-2 knockin mouse ( HA Npn-2) in which a 2xHA epitope coding sequence was inserted in the endogenous Npn-2 locus downstream of the Npn-2 signal sequence ( Figure S2A and STAR Methods). Using an HA antibody for western blot analysis, we detected a signal at a molecular weight similar to wild-type Npn-2 protein in brain lysates derived from HA Npn-2 mice ( Figure S2B ). Importantly, we did not observe any of the deficits previously associated with Npn2 null mutants (Tran et al., 2007) 
HA
Npn-2-derived cortical neuron cultures were transfected with a plasmid encoding green fluorescent protein (GFP), and using an HA antibody, we detected HA Npn-2 protein at dendritic spines ($72% of spines contain HA-Npn2 signal) ( Figure 3A) . A significant fraction of HA Npn-2 puncta colocalizes with GluA1 puncta in cortical neuron cultures ( Figure 3B : $68% GluA1 colocalization with HA Npn-2, and $30% HA Npn-2 colocalization with GluA1), and most vGlut1 + puncta (a presynaptic terminal marker for excitatory glutamatergic synapses) are juxtaposed to HA Npn-2 puncta ( Figure S2C ). Wild-type neurons derived from littermate controls did not show HA antibody staining ( Figure S2B ). We next asked whether Npn-2 is required for activity-induced downscaling of cell surface AMPARs. We treated cortical cultures (14 DIV) derived from E14. 3F ). Previously reported homeostatic synaptic scaling resulting from changes in neural activity is mostly reported from cortical cultures derived from older brains (Shepherd et al., 2006; Diering et al., 2014 3C-3F). These results show that Npn-2 is required for bicuculline-induced cell surface AMPAR downscaling.
To assess the functional role played by Npn-2 in synaptic scaling, we recorded mEPSCs from neurons in wild-type or Npn-2 À/À cortical cultures derived from E18 embryos. Consistent with previous reports (O 'Brien et al., 1998; Turrigiano et al., 1998) , 48 hr of bicuculline treatment decreases AMPARmediated mEPSC amplitude in wild-type cultures (Figures 4A and 4B) . However, Npn-2 À/À cortical neurons failed to exhibit a significant bicuculline-induced decrease in synaptic strength ( Figures 4A and 4B ). We did not observe significant differences between mEPSC frequency in bicuculline-treated wild-type or Npn-2 À/À cortical neurons ( Figure S3A ). Further, no difference in resting membrane potential or cell capacitance was observed (Figures S3F and S3G) , indicating similar intrinsic excitability and comparable cell size between groups. We next used PSD95 as a synaptic marker (Huganir and Nicoll, 2013) to specifically monitor cell surface distribution of postsynaptic GluA1 and found that the reduction in synaptic GluA1 by bicuculline is abolished in E18 Npn-2 À/À cortical cultures ( Figures 4C and   4D ). We also assessed the acute effect of Sema3F on mEPSC frequency and amplitude. In line with our biochemical assessment of GluA1 cell surface level changes upon Sema3F treatment ( Figures 2E and 2F ), we found that after 4 hr of Sema3F treatment, cultured wild-type or Npn2 À/À cortical neurons showed no significant differences in mEPSC amplitude or frequency ( Figures S3H and S3I ). These observations are consistent with previous assessments of changes in AMPAR cell surface expression during homeostatic scaling (O'Brien et al., 1998; Turrigiano et al., 1998) . These functional data, together with our cell surface staining and biochemical analyses, demonstrate that Npn-2 is required for downscaling of AMPAR-mediated synaptic strength upon chronic activity elevation. Straub and Tomita, 2012; Vernon and Swanson, 2017; Wang et al., 2012a) . Similar to these proteins, the N-terminal portion of the Npn-2 extracellular domain harbors two CUB domains (Pasterkamp, 2012) . Since Npn-2 is enriched in PSD fractions, and since synaptic transmission is altered in Npn-2 À/À cortical neurons in slice culture (Sahay et al., 2005; Tran et al., 2009 ), these observations raise the possibility that Npn-2, too, interacts with glutamate receptors. We assessed binding between Npn-2 and glutamate receptors in vitro, co-transfecting 293T cells with N-terminal FLAG-tagged Npn-2 and a range of glutamate receptors ( Figure 5A ). We found that Npn-2 coimmunoprecipitates most robustly with GluA1, and to a much lesser extent with GluA2 ( Figure 5A ). Npn-2 does not coimmunoprecipitate with other glutamate receptors, including the kainate receptor subunit GluK2, which interacts with the CUB domain-containing transmembrane proteins Neto1 and Neto2, or the NMDAR subunit NR2A, which interacts with Neto1 (Greger et al., 2017; Howe, 2015; Jackson and Nicoll, 2011; Straub and Tomita, 2012; Vernon and Swanson, 2017; Wang et al., 2012a) (Figures 5A and 5B) .
Neuropilin-2 Selectively Associates with AMPARs
Since the association between Npn-2 and GluA1 is most robust, we chose to further characterize functional interactions between these two proteins, but we note that GluA2 also interacts with Npn-2, though apparently to a much lesser extent ( Figure 5A ).
To examine potential interactions between endogenous Npn-2 and GluA1 in vivo, we immunoprecipitated GluA1 from solubilized crude membrane fractions harvested from wildtype P42 adult mouse cortices and immunoblotted for Npn-2. Npn-2 coimmunoprecipitates with GluA1 ( Figure 5C ) and with GluA2, albeit much less robustly ( Figure S4B ). Importantly, coimmunoprecipitation of GluA1 using Npn-2 antibodies was observed in wild-type, but not Npn-2
, P42 brain lysates ( Figure 5D ). Similar coimmunoprecipitation experiments from lysates derived from primary cortical neuron cultures revealed coimmunoprecipitation of Npn-2 with GluA1 ( Figure S4A ). However, Npn-1, which is closely related to Npn-2, does not associate with GluA1 in solubilized crude membrane fraction lysates derived from wild-type mouse brains ( Figure S4C ). These results are complemented by in vitro coimmunoprecipitation experiments in which FLAG-tagged Npn-1, Npn-2, or TrkB were overexpressed together with HA-tagged GluA1 in 293T cells. Cell lysates were immunoprecipitated with an HA antibody and the resulting immunoprecipitates immunoblotted with a FLAG antibody. Only FLAG-Npn-2, and not FLAGNpn-1 or FLAG-TrkB, coimmunoprecipitates with HA-GluA1 ( Figure 5E ). Therefore, Npn-2 interactions with glutamate receptor subtypes are selective, and Npn-2 interacts most strongly (C) Coimmunoprecipitation of GluA1 and Npn-2 from wild-type mouse brain lysates. GluA1 was immunoprecipitated from brain lysates and then immunoblotted using an Npn-2 antibody. Input was 1% of the total lysate used for the coimmunoprecipitation. Arrow indicates Npn-2 protein band (n = 4 experiments). (D) Coimmunoprecipitation of Npn-2 and GluA1 from wild-type mouse brain lysates and from Npn-2 À/À brain lysates as a negative control.
Npn-2 was immunoprecipitated from brain lysates and immunoprecipitates immunoblotted using a GluA1 antibody. Arrow indicates GluA1 protein band.
(E) Coimmunoprecipitation of HA-GluA1 with FLAGtagged Npn-1, Npn-2, or TrkB from transfected HEK293T cells lysates. HA-GluA1 was immunoprecipitated with an HA antibody, and the resulting immunoprecipitates were subjected to immunoblotting using a FLAG antibody (n = 3 experiments).
(F) PlexA3 forms a complex with GluA1 and Npn-2. HEK293T cells were transfected with combinations of constructs expressing HA-GluA1, FLAGNpn-2, and Myc-PlexA3. A Myc antibody was used for immunoprecipitation and the immunoprecipitates were immunoblotted using either anti-HA to detect GluA1 or anti-FLAG to detect Npn-2 (n = 3 experiments). See also Figure S4 with GluA1. Npn-2 also interacts with the proteins 4.1N and SAP97, though apparently much less robustly as compared to the interaction between GluA1 and these synaptically localized proteins ( Figures S4D and S4E ) To determine the relationships among Npn-2, PlexA3, and GluA1 with respect to protein complex formation, we expressed combinations of these proteins in 293T cells and assessed their coimmunoprecipitation with GluA1 ( Figures 5F, S4F , and S4G). GluA1 interacts with Npn-2 equally well in the presence or absence of PlexA3 ( Figure S4G ), suggesting that PlexA3 does not contribute to the GluA1 binding site of this complex and does not compete with GluA1 for Npn-2 binding. PlexA4, a plexin similar to PlexA3, interacts directly with GluA2 (Yamashita et al., 2014) , so we tested PlexA3 for direct binding to GluA1 by expressing both proteins in 293T cells; however, GluA1 does not coimmunoprecipitate with PlexA3 in 293T cells in the absence of Npn-2 ( Figure 5F ). Nevertheless, in the presence of Npn-2, PlexA3 is part of a complex that includes GluA1 (Figures 5F and S4F). These results show that although GluA1 does not associate with PlexA3 directly, Npn-2 facilitates the formation of a GluA1/Npn-2/PlexA3 complex.
Sema3F and Neuronal Activity Regulate the Interaction between Npn2 and GluA1
Since alterations in neuronal activity modulate Sema3F secretion, and since cortical neurons in culture obtained from Sema3F À/À mutants show deficits in bicuculline-mediated GluA1 cell surface downscaling (Figures 1 and 2 ), we wondered whether Sema3F influences the association between Npn-2 and GluA1. To assess Sema3F effects on GluA1 association with Npn-2 in the context of the Sema holoreceptor complex, we expressed GluA1 together with Npn-2 and PlexA3 in 293T cells. Transfected cells were treated with 5 nM Sema3F at various time points up to 6 hr, GluA1 was immunoprecipitated, and co-immunoprecipitated Npn-2 was detected by western blot. Following treatment with Sema3F, the association between Npn-2 and GluA1 was decreased significantly (Figures 6A and 6B) . This effect was greatest 30 min following Sema3F treatment, and this disruption of the association between GluA1 and Npn-2 was diminished over time. Next, we examined Sema3F modulation of the interaction between Npn-2 and GluA1 in mouse cortical cultures. Similar to our observations in 293T cells, Sema3F treatment leads to a reduction in the association between Npn-2 and GluA1, and this effect follows a time course similar to our observations in 293T cells ( Figures 6C and 6D) . Therefore, Sema3F modulates the association between Npn-2 and GluA1.
Secreted Semas such as Sema3A bind to neuropilin receptors through the neuropilin N-terminal CUB domains, and mutations that affect select amino acids in the first Npn-1 CUB domain (CUB1) result in the inability of Sema3A to bind to Npn-1 and to signal repulsive axon guidance (Gu et al., 2003) . Based on amino acid identities and similarities between Npn-2 and Npn-1, we made six single amino acid changes in the Npn-2 CUB1 domain modeled on those we made previously in Npn-1 that abrogate Sema3A ligand binding (Gu et al., 2003) , to generate an altered receptor called Npn-2 Sema3F-. AP-Sema3F fails to bind to COS7 cells expressing Npn-2 Sema3F-, unlike those expressing wild-type Npn-2 ( Figure S5A ). Surface biotinylation experiments show that Npn-2 Sema3F-cell surface expression levels in COS7 cells are comparable to those of wild-type Npn-2 ( Figure S5B ). To further investigate how Sema3F modulates the Npn-2/ GluA1 interaction, we used Npn-2 Sema3F-in our in vitro coimmunoprecipitation assay following Sema3F treatment. GluA1 and PlexA3 robustly associate with Npn-2 Sema3F-in a manner similar to wild-type Npn-2 ( Figures S5C and S5D ), suggesting that GluA1/Npn-2 interactions depend on Npn-2 CUB domain regions distinct from those required for Sema3F binding. When GluA1 was expressed together with Npn2
Sema3F-and PlexA3 in 293T cells, Sema3F treatment failed to reduce the association between GluA1 and Npn2 Sema3F-( Figures 6E and 6F ). These results show that Sema3F-mediated negative modulation of GluA1/Npn-2 association requires Sema3F binding to Npn-2.
Since chronic bicuculline treatment (48 hr) increases Sema3F levels in mouse cortical neuron culture media ( Figures 1C-1F ), we next asked whether increasing neuronal activity via bicuculline treatment regulates GluA1/Npn-2 interactions. Lysates obtained from untreated mouse cortical cultures, or cultures treated with bicuculline for 48 hr, were immunoprecipitated with a GluA1 antibody and assessed for Npn-2 coimmunoprecipitation. Bicuculline treatment results in reduced coimmunoprecipitation of Npn-2 with GluA1 ( Figures 6G and 6H) . However, the association between Npn-2 and GluA1 remains unchanged in Sema3F À/À cortical cultures following bicuculline treatment (Figures 6G and 6H) , demonstrating the dependence upon Sema3F for the ability of activity increases to modulate Npn-2/GluA1 association. Further, a combination of bicuculline and Sema3F fails to further reduce Sema3F-mediated disassociation of Npn-2 from GluA1 ( Figures S5E and S5F ), suggesting that Sema3F and bicuculline act in the same pathway to regulate Npn-2/ GluA1 association. These results support a model whereby neuronal activity abrogates the association between GluA1 and Npn-2 in part by regulating Sema3F signaling.
Npn-2 Associates with GluA1 through Its CUB Domains
Since the Neto protein CUB domains mediate interactions between Neto1 and Neto2 and the GluK2 kainate receptor (Greger et al., 2017; Howe, 2015; Jackson and Nicoll, 2011; Straub and Tomita, 2012; Vernon and Swanson, 2017; Wang et al., 2012a) , we next used Npn-2 ectodomain deletion mutants ( Figures 7A and 7B ) to map extracellular protein domains required for Npn-2 interactions with GluA1. We transfected 293T cells with individual Npn-2 deletion constructs and GluA1 and assessed their association. Cell surface biotinylation experiments show that these Npn-2 variants are expressed on the cell surface at levels equivalent to wild-type Npn-2 and that Sema3F retains the ability to bind to all of these deletion mutants, with the exception of those lacking the CUB domains ( Figures  S5B and S6A ; data not shown). Npn-2 lacking either one or both CUB domains fails to interact with GluA1, but deletion of either the Npn-2 type V/VIII coagulation factor domains or the MAM domain does not affect GluA1 association ( Figure 7B ). To confirm that Npn-2 CUB domains mediate the interaction between Npn-2 and GluA1, we substituted both Npn-1 CUB domains in an otherwise wild-type Npn-1 protein with both Npn-2 CUB domains to generate a chimeric receptor (Npn-1 Npn-2CUB ). This swap of Npn CUB domains changes the ligand-binding capacity of the receptor since AP-Sema3F, but not AP-Sema3A, binds Npn-1 Npn-2CUB in COS7 cells (Figure S6A ). Though Npn-1 does not interact with GluA1 either in vitro or in vivo ( Figures 5E and S4C ), Npn-1 Npn-2CUB coimmunoprecipitates with GluA1 in 293T cells, similar to Npn-2 (Figure 7C) . We next generated a chimeric Npn-2 in which the second Npn-2 CUB domain, CUB2, is replaced with the Npn-1 CUB2 domain (Npn-2 Npn-1CUB2 ). Npn-2 Npn-1CUB2 still binds Sema3F ( Figure S6A ) but lacks the ability to interact with GluA1 ( Figure 7D ). Taken together, these results show that both Npn-2 CUB domains together mediate the interaction between Npn-2 and GluA1, and that Npn-2 domain requirements for binding to Sema3F or to GluA1 are separable.
Npn-2 Is Required Cell Autonomously for Cell Surface GluA1 Downscaling
We next asked whether Npn-2 is required cell autonomously for bicuculline-induced cell surface AMPAR downscaling. We cultured primary cortical neurons derived from Npn-2 F/-conditional mutant embryos (Gu et al., 2003) , and at 12 DIV we transfected them with either a CRE-IRES-GFP-expressing plasmid, to remove Npn-2 expression in individual neurons, or with a (A) Regulation of the interaction between HAGluA1 and FLAG-Npn-2 in HEK293T cells by Sema3F. HEK293T cells transfected with HAGluA1, FLAG-Npn-2, and Myc-PlexA3 constructs were treated with AP-Sema3F (5 nM) for the indicated times. Npn-2 was co-immunoprecipitated with GluA1 from the transfected cell lysates using an HA antibody. (B) Quantification of Npn-2 coimmunoprecipitations with GluA1 from transfected HEK293T cell lysates following Sema3F treatment (n = 3 experiments). For quantification, the intensity of coimmunoprecipitated Npn-2 was normalized to the intensity of Npn-2 input, and the value of the normalized control sample (0 min) was set as 100%. (C) Sema3F regulation of the interaction between GluA1 and Npn-2 in cortical neurons. 14 DIV cortical neurons were treated with 5 nM Sema3F for the indicated times, and cell lysates were collected and subjected to coimmunoprecipitation using a GluA1 antibody. (D) Quantification of the Npn-2 interaction with GluA1 upon Sema3F treatment relative to the untreated control, presented in (C) (n = 3 experiments). Quantification was performed as described in (B). (E) HEK293T cells were transfected with constructs expressing either wild-type FLAG-Npn-2 or FLAG-Npn-2 Sema3F-together with HA-GluA1 and Myc-PlexA3. Transfected cells were treated with either AP or AP-Sema3F for 30 min.
(F) Quantification of experiments in (E), showing that Sema3F treatment fails to modulate the interaction between Npn-2 Sema3F-(Npn-2 lacking the ability to bind Sema3F) and GluA1 (n = 3 experiments). Quantification was performed as described in (B).
(G) Neuronal activity regulates the interaction between Npn-2 and GluA1. Cortical cultures (14 DIV) derived from wild-type or Sema3F À/À embryos were treated with bicuculline or control media for 48 hr; cell lysates were collected and subjected to co-immunoprecipitation with a GluA1 antibody.
(H) Quantification of (G). Coimmunoprecipitated Npn-2 following bicuculline treatment was quantified relative to the untreated sample. Quantification was performed as described in (B) (n = 3 experiments). See also Figure plasmid expressing IRES-GFP as a control ( Figure 7E ). At 14 DIV, neurons were treated for 48 hr with either TTX or bicuculline and then subjected to live labeling to assess surface GluA1 expression. Transfected cortical neurons were identified by GFP expression, and individual segments of GFP-positive dendrites were used for the quantification of cell surface GluA1 levels. We observed increases and decreases in surface GluA1 along the dendrites of GFP-expressing control cortical neurons following treatment with TTX or bicuculline, respectively ( Figures  7E and 7F) . However, though CRE-IRES-GFP-expressing Npn-2 F/-cortical neuron dendrites (lacking Npn-2 owing to CRE-mediated recombination) exhibit increases in cell surface GluA1 levels following TTX treatment, there was no significant bicuculline-induced GluA1 downscaling ( Figures 7E and 7F) . Moreover, bicuculline-induced GluA1 downscaling was rescued in CRE-IRES-GFP-expressing Npn-2 F/-cortical neurons following transfection with an Npn-2-expressing plasmid. The abolition of the bicuculline-induced GluA1 downscaling in individual neurons lacking Npn-2 expression, and the restoration of this downscaling effect following introduction of Npn-2 in these neurons, reveals a neuron-autonomous role for Npn-2 in mediating GluA1 downscaling in response to increased neural activity ( Figures 7E and 7F) . To further address cell-autonomous Npn-2 function in synaptic scaling, we introduced an Npn-2 short-hairpin RNA (shRNA) plasmid into rat cortical neurons derived from E18 embryos in order to knock down endogenous Npn-2 protein in individual neurons ( Figure S6B ). We observed similar GluA1 downscaling deficits in bicuculline-treated Npn-2 shRNA-expressing rat neurons to those we found in mouse neurons ( Figures S6C and S6D) . Therefore, Npn-2 is cell autonomously required in cortical neurons for bicuculline-induced GluA1 downscaling.
Npn-2 Association with Sema3F and GluA1 Are Both Required for GluA1 Downscaling following Elevation of Neural Activity
We next asked whether Npn-2 Sema3F-could rescue the defect in bicuculline-induced GluA1 cell surface downscaling that we observed when Npn-2 F/-neurons were transfected with CRE-IRES-GFP. Unlike wild-type Npn-2, Npn-2 Sema3F-was not able to restore bicuculline-induced GluA1 downscaling following CRE-mediated loss of Npn-2 ( Figures 7E and 7F) . Therefore, Sema3F binding to Npn-2 is required for GluA1 downscaling following an increase in neuronal activity.
If the association between GluA1 and Npn-2 is important for AMPAR downscaling in response to increased neuronal activity, our expectation is that Npn-2 DCUB2 would fail to rescue GluA1 downscaling in neurons lacking Npn-2, since Npn-2 DCUB2 is unable to associate with GluA1 in 293T cells ( Figure 7B ). Indeed, Npn-2 F/-cortical neurons transfected with plasmids expressing CRE and Npn-2 DCUB2 exhibit no changes in their cell surface GluA1 levels following bicuculline treatment ( Figures 7E and 7F ). Npn-2 DCUB2 does not bind to Sema3F (Figure S6A ) or to GluA1 ( Figure 7B ). To separate Sema3F and GluA1 binding requirements for GluA1 downscaling, we asked whether Npn-2 Npn-1CUB2 ( Figure 7A ), which binds Sema3F but not GluA1 ( Figures S6A and 7D ), rescues GluA1 downscaling in neurons lacking Npn-2. We found that Npn-2 Npn-1CUB2 , like
Npn-2 Sema3F-, does not rescue bicuculline-mediated GluA1 downscaling in the absence of wild-type Npn-2 ( Figures 7E  and 7F ). These data show that the interaction between Npn-2 and GluA1, even if Sema3F interactions with Npn-2 are intact, is essential for bicuculline-induced GluA1 downscaling. Therefore, Npn-2 binding to both Sema3F and GluA1 is essential for cell surface AMPA receptor downscaling following elevations in neuronal activity.
PlexA3 Is Required for Sema3F Modulation of
Interactions between Npn-2 and GluA1, and for Cell Surface GluA1 Downscaling Since Sema3F and Npn-2 are required for bicuculline-induced downscaling of cell surface GluA1, and also since our data show that PlexA3 forms a complex with Npn-2 and GluA1 (Figures 5E and S4F), we next asked whether PlexA3 is also required for GluA1 downscaling. Primary cortical cultures derived from PlexA3 À/À mice were treated with either TTX or bicuculline and assessed for surface GluA1 expression by live immunofluorescence staining and surface biotinylation ( Figures  S7A-S7D ). TTX treatment increases surface GluA1 expression significantly in PlexA3 À/À mutant neurons, similar to what we observed in wild-type cultures. However, bicuculline-induced reduction in cell surface GluA1 expression is attenuated in PlexA3 À/À mutant neurons. Therefore, the Npn-2/PlexA3 holoreceptor complex is required for cell surface AMPAR homeostatic downscaling. To ask whether PlexA3 regulates Sema3F-mediated modulation of the association between GluA1 and Npn-2, we treated 293T cells expressing GluA1 and Npn-2, but not PlexA3, with Sema3F and found that Sema3F failed to reduce the interaction between GluA1 and Npn-2 ( Figures 8A and 8B) . We next repeated this experiment including a modified PlexA3 receptor lacking its intracellular domain, PlexA3
DCyto , and found that Sema3F failed to reduce the association between GluA1 and Npn-2 ( Figures S7E and S7F) . Thus, the intracellular region of PlexA3 is required for Sema3F to mediate the dissociation of GluA1 from the GluA1/Npn-2/PlexA3 complex, strongly suggesting that PlexA3 receptor signaling mediates this effect. Is Sema3F/Npn-2/PlexA3 downstream signaling essential for AMPAR downscaling? We expressed PlexA3
DCyto , which functions as a dominant-negative PlexA3 receptor for semaphorinmediated repulsive axon guidance (Takahashi et al., 1999) , in
Cre-expressing plasmids (pCAGGS-IRES-GFP was used as a control). Transfected neurons were identified by GFP fluorescence. Shown are segments of mouse cortical neuron dendrites immunostained for GluA1 and GFP.
(F) Quantification of cell surface GluA1 immunostaining in transfected neurons in (E) (n = 45 transfected neurons for each condition, and 10-15 dendritic segments from each individual neuron were assessed). See also Figure S6 . *p < 0.05, **p < 0.01; ns: not significant. Statistical comparisons were performed using two-way ANOVA with Tukey's HSD. in which the PlexA3 RasGAP activity is abolished by mutating two critical arginine residues in the GAP domain that makes up part of the PlexA cytoplasmic domain (Duan et al., 2014) . Plex-A3 AA binds to Npn-2 (data not shown); however, Sema3F failed to reduce the Npn-2/GluA1 association in 293T cells expressing Npn-2, GluA1, and PlexA3 AA ( Figures S8A and S8B ). We next asked whether PlexA3 RasGAP activity is important for its role in cell surface AMPA receptor downscaling. Cortical cultures derived from PlexA3 À/À embryos transfected with wild-type PlexA3 showed normal cell surface GluA1 downscaling ( Figures  8C and 8D ). However, PlexA3 AA failed to rescue the PlexA3 mutant GluA1 downscaling defect ( Figures 8C and 8D ).
The RacGAP b2-Chimaerin (Chn2) mediates Sema3F-dependent hippocampal infrapyramidal tract (IPT) pruning, but it is not required for Sema3F-mediated axon repulsion or dendritic spine constraint (Riccomagno et al., 2012) . We asked whether b2-Chimaerin is involved in Sema3F-dependent AMPA receptor downscaling using cortical cultures derived from Chn2 À/À embryos and assessing surface GluA1 levels following TTX or bicuculline treatment (Figures S8C-S8F ). Chn2 À/À cortical neurons in culture do not show a significant alteration in response to TTX or bicuculline challenge; thus, Sema3F-depedent cell surface synaptic AMPAR downscaling does not utilize signaling components that mediate Sema3F axon pruning. Taken together, these results show that PlexA3, a signaling receptor component of the Sema3F holoreceptor, is required both for Sema3F regulation of Npn-2/GluA1/PlexA3 complex formation and also cell surface GluA1 downscaling following an elevation in neuronal activity. Moreover, PlexA3 RasGAP activity is essential for cell surface AMPAR downscaling. 
DISCUSSION
We show here that the secreted semaphorin Sema3F and its Npn-2/PlexA3 holoreceptor are required in cortical neurons for cell surface AMPAR downscaling during homeostatic synaptic plasticity resulting from an increase in neural activity. Npn-2 joins an increasing number of CUB domain-containing proteins that bind to glutamate receptors and thereby regulate synapse function. Sema3F/Npn-2 interactions are required for AMPAR downscaling, and treatment with Sema3F attenuates the association between Npn-2 and GluA1, which requires an intact PlexA3 receptor. Since elevated neuronal activity promotes Sema3F secretion, our results suggest that homeostatic scaling responses to increased neural activity result in Sema3F-mediated, PlexA3-dependent, diminution of the association between Npn-2 and GluA1 ( Figure 8E ).
Sema3F signaling is not required for upscaling of cell surface AMPARs, underscoring the roles played by distinct signaling mechanisms in up and down homeostatic scaling. While our study was in revision, a very recent study showed that retrograde secreted Sema-2b/Plexin B signaling is critical for regulating homeostatic control of presynaptic neurotransmitter release at the Drosophila larval neuromuscular junction (NMJ) (Orr et al., 2017) . In addition, neural activity at the Drosophila larval NMJ enhances signaling by the secreted semaphorin Sema2a, which constrains off-target motor axon contacts and synaptogenesis (Carrillo et al., 2010) . Though the signaling mechanisms that regulate Sema2b-mediated presynaptic homeostatic scaling, Sema2a-medated constraint of motor axon contacts and synaptogenesis, and Sema3F-mediated postsynaptic homeostatic scaling in mammalian cortical neurons appear distinct, together these studies highlight diverse semaphorin-plexin signaling events that regulate synaptic function following the initial elaboration of neural connectivity.
We also find that a chronic increase in neuronal activity promotes Sema3F secretion in cultured cortical neurons and that Sema3F is critical for AMPAR downscaling following elevation of neuronal activity. One likely source of Sema3F is excitatory neurons themselves, and future work utilizing conditional celltype-specific Sema3F ablation will fully address this issue. Our results suggest that Sema3F is part of a feedback loop in which increased neuronal activity leads to elevated Sema3F secretion and this in turn drives semaphorin signaling at excitatory synapses, downscaling cell surface AMPARs and decreasing synaptic strength in order to constrain overall network activity.
The association between GluA1 and Npn-2 requires both of the Npn-2 CUB domains. Together with the lack of AMPAR downscaling in Npn-2 À/À neurons and the requirement for the Npn-2 CUB domains in AMPAR downscaling rescue experiments in cortical neurons even in the context of preserved Sema3F binding, our results strongly suggest that Npn-2 binding to GluA1 is essential for activity-induced GluA1 downscaling. Several CUB domain-containing proteins interact with various neurotransmitter receptors and regulate channel localization, trafficking, and biophysical properties. The C. elegans CUB domain-containing proteins SOL-1 and SOL-2 regulate glutamate receptor channel properties, C. elegans LEV-10 mediates AChR clustering, Drosophila Neto interacts with iGluRs and participates in clustering glutamate receptors at the NMJ, and mammalian Neto1 and Neto2 are well-characterized kainate and NMDA glutamate receptor auxiliary subunits that associate with these neurotransmitter receptors through their CUB domains and regulate receptor channel properties (Greger et al., 2017; Howe, 2015; Jackson and Nicoll, 2011; Straub and Tomita, 2012; Vernon and Swanson, 2017; Wang et al., 2012a) . Vertebrate Neto proteins also directly contribute to kainate receptor surface expression and synaptic localization, though each of the Neto1 and Neto2 CUB domains appears to contribute in a somewhat additive fashion to glutamate receptor binding. We find that both Npn-2 CUB domains are required for Npn-2 binding to GluA1, and this may reflect differences in the mechanisms underlying how these CUB domain-containing proteins regulate neurotransmitter receptor cell surface expression and/or function. Npn-2 differs from the rest of these proteins with respect to ligand-dependent influences on glutamate receptor binding and cell surface localization, and our observations underscore the importance of ligand-gated interactions with Npn-2 for regulating homeostatic scaling. We predict that there are differences in how Npn-2 associates with AMPA receptors compared to Neto1 and Neto2 interactions with kainate and NMDA receptors. Further, our results show that binding of the Npn-2/PlexA3 holoreceptor complex to GluA1, and regulation of this association by Sema3F, are both required for homeostatic cell surface GluA1 downscaling. It will be interesting to determine how Sema3F alters the dynamics of GluA1 cell surface expression and also the biophysical properties of AMPAR neurotransmission. It will also be important to investigate how neural activity regulates Sema3F secretion and to determine whether this results from increased calcium transients or, perhaps, the direct action of immediate-early genes, to increase Sema3F transcription, translation, or activity-dependent effects that directly impact Sema3F secretion. We find that PlexA3, the major signaling component of the Sema3F holoreceptor, is required for AMPAR downscaling and for Sema3F-mediated dissociation of GluA1 from Npn-2. Semaphorins act through multiple signaling cascades in a variety of cell types (Pasterkamp, 2012) . The plexin intracellular domain harbors a GTPase activating protein (GAP) activity that has been shown to act on R-Ras and also on Rap1 (Pasterkamp, 2012; Wang et al., 2013) . The PlexA2 GAP activity is required for the transmembrane semaphorin Sema5A to restrict dendritic spine formation in hippocampal dentate granule cells (Duan et al., 2014) . We find here that PlexA3 GAP activity is also essential for cell surface AMPAR downscaling. Plexin signaling can also involve the action of RhoGTPases, several cytosolic kinases, and redox modification of the actin cytoskeleton (Wilson et al., 2016) , and future work will address whether any of these signaling components impact postsynaptic homeostatic scaling mechanisms. Our findings here contrast with previous work showing that PlexA4 directly interacts with GluA2 in axons of cultured hippocampal neurons, serving to facilitate GluA2 transport into dendrites and to regulate dendritic branching (Yamashita et al., 2014) , and it remains to be determined whether this PlexA4 function impacts excitatory synaptic transmission or plasticity.
Post-translational modifications including phosphorylation, ubiquitination, and palmitoylation are important regulatory mechanisms underlying AMPA receptor trafficking (Anggono and Huganir, 2012) , and recent work demonstrates the critical role played by protein kinase A (PKA) in regulating the phosphorylation status of AMPARs to mediate synaptic downscaling (Diering et al., 2014) . PKA signaling is implicated in semaphorin signaling relating to axon guidance in both invertebrates and vertebrates (Pasterkamp, 2012; Yang and Terman, 2012) , and so it will be of interest to determine whether Sema3F signaling results in PKA activation and subsequent regulation of AMPAR trafficking.
Mounting evidence suggests that signaling proteins and pathways implicated in a wide range of neurological diseases also impact homeostatic scaling. For example, MeCP2, which when deficient is associated with Rett syndrome, and FMRP, which is implicated in Fragile X Syndrome, contribute to homeostatic up-and downscaling (Blackman et al., 2012; Qiu et al., 2012; Soden and Chen, 2010) . Sema3F and Npn-2 mutant mice, including Npn-2 heterozygous animals, are prone to spontaneous seizure activity (Koropouli and Kolodkin, 2014) . These observations, in combination with current thinking regarding the relationship between homeostatic plasticity and epilepsy (Swann and Rho, 2014) , shed light on how Sema3F-Npn-2 signaling may contribute to maintaining the balance between excitation and inhibition to control overall network homeostasis. Further, local scaling interactions may also be regulated by Sema3F following the activation of individual synapses and subsequent weakening of neighboring ones (Mullins et al., 2016) . Secreted semaphorin-mediated regulation of homeostatic scaling at mature synapses provides examples of how signaling cascades critical for neural development also impact adult neural plasticity, encouraging further exploration into the degree to which neural developmental mechanisms underlie adult synapse function in health and disease.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
METHOD DETAILS
Generation of Myc Sema3F Knockin Mice
The targeting vector was made using a homologous recombination-mediated gene targeting strategy, as described (Liu et al., 2003) ( Figures S1A and S1B ). Briefly, a Sema3F BAC clone was used for the retrieval of a Sema3F genomic DNA sequence that included exon 2 and genomic sequences upstream and downstream of exon 2, which made up the long and short homology arms, respectively; these were cloned into the PBS-DTA vector, resulting in the gap-repaired plasmid. DTA encodes for diphtheria toxin A, which served as a negative selection marker during ES cell screening. The long homology arm consisted of $9,580 base pairs and extended upstream of exon 2, whereas the short arm consisted of 1,720 base pairs and extended downstream of exon 2. Next, the nucleotide sequence encoding the 6xMYC epitope was subcloned into the second exon of Sema3F, between DNA sequences encoding the amino acids L26 and P27, eight amino acids downstream of the predicted signal sequence cleavage site, which lies between P18 and A19. Subsequently, short genomic fragments flanking the tag insertion site were subcloned on either side of the epitope tag and a LoxP-NEO-LoxP (LNL) cassette was inserted 510 base pairs downstream of the exon 2 coding sequence. NEO, encoding for neomycin, serves as a positive selection marker. This modified Sema3F genomic sequence was subcloned in the PL451 vector and the plasmid, known as a mini-targeting vector, carried all the desired modifications to be inserted in the Sema3F locus (i.e., epitope tag and NEO cassette). This modified genomic fragment was introduced into the Sema3F gap-repaired plasmid by homologous recombination, resulting in the finished targeting vector. The targeting vector was sequenced and linearized, and the Johns Hopkins Transgenic Mouse Core electroporated it into embryonic stem cells. Clones of transfected cells were positively selected with neomycin, and diphtheria toxin A expression served as a negative selection for incorrect clones. Clones able to grow under these selection conditions were screened using PCR and positive clones were further tested with karyotyping and Southern blot. Finally, the correct clones were injected into 129S6/SvEvTac mouse blastocysts for the generation of chimeric mice, and chimeras were crossed with wild-type mice to obtain germline transmission. Figures  S1C and S1D ). The sequences of these primers are: forward primer (anneals upstream of exon 2): 5 0 -tgagccgagggctatgagcatgg -3 0 , reverse primer (anneals downstream of exon 2): 5 0 -tgcagggaaaccagcactgtgagg À3 0 . The primers of the second pair were used to detect the Myc Sema3F allele since the forward primer anneals to the epitope tag sequence; therefore, this PCR approach distinguishes mice harboring the Myc Sema3F allele (heterozygous and homozygous mice) from wild-type mice. The size of this PCR product is 607 base pairs. The sequences of these primers are: forward primer: 5 0 -gagagcttgggcgacctcaccatg À3 0 and reverse primer: 5 0 -cgatgaattcggcactgggttattaaagtactccgtgg -3 0 .
Generation of HA Npn-2 knockin mice HA Npn-2 knockin mice were generated using CRISPR-Cas9 homologous recombination. Briefly, the Npn-2-specific sgRNA (CTTCCAGATCCACCCTGCGG) sequence was selected according to http://crispr.mit.edu and cloned into the px330 plasmid (Cong et al., 2013) . The T7 promoter was added to Cas9 and sgRNA templates by PCR amplification. For the homologous recombination template, single stranded ultramer oligonucleotides were from Integrated DNA Technologies (IDT DNA). The 3X HA tag was designed to be inserted 3 amino acids downstream of the Npn-2 signal peptide. The templates were generated that matched flanking Npn-2 genomic DNA sequences 80 base pairs from the insertion site on each side of the 3XHA tag DNA sequences. mRNAs encoding Cas9 and sgRNA plus the template were injected into C57BL/6 fertilized eggs. The injected zygotes were cultured until the blastocyst stage and then transferred into pseudopregnant ICR females. Founder chimeric mice were PCR-genotyped and mated with C57BL/6 mice to obtain the first generation of knockin mice. Correct insertions of HA-tags were identified by sequencing the Npn-2 genomic region, and the expression of HA-tagged Npn-2 was identified by western blot using an HA-antibody (Biolegend 16B12). Due to aberrant recombination events, we obtained multiple lines of HA Npn2 knockin mice with various numbers of HA tags (1X, 2X and 3X). Here, we report our results based on the confirmed 2XHA-tagged Npn-2 line.
Antibodies and Chemicals
Primary antibodies: mouse-anti-GluA1 (4.9D- (Diering et al., 2014) , mouse-anti-GluA2 - (Diering et al., 2014) ), mouse-anti-FLAG (M2, Sigma), mouse-anti-HA (12CA5, Roche), mouse-anti-HA (16B12, Biolegend), mouse-anti-Myc (Sigma), mouse-anti-PSD95 (NeuroMab), rabbit-anti-Myc (Cell Signaling), rabbit-anti-Npn-2 (Cell Signaling), rabbit-anti-HA (Sigma), rabbit-anti-HA (Cell Signaling, monoclonal), chicken-anti-GFP (Aves), guinea pig anti-GluA1 (Alomone Labs), guinea pig anti-vGlut1 (Millipore), ratanti-Ctip2 (Abcam) and rat-anti-HA (3F10, Roche). Secondary antibodies: Alexa Fluor-conjugated secondary antibodies (Molecular Probes) for immunofluorescence; horseradish peroxidase-conjugated secondary antibodies (GE Healthcare) for western immunoblot analysis. Chemicals: Bicuculline methobromide (Tocris), tetrodotoxin citrate (TTX) (Tocris).
Primary Neuron Transfection
At 12 DIV, cultured neurons were transfected using Lipofectamine 2000 (ThermoFisher Scientific). Specifically, Neurobasal media containing 1 mg of indicated plasmids was mixed with Neurobasal media containing 1 mL of Lipofectamine 2000 reagent and allowed to sit at room temperature for 20 min. The resulting mixtures were added to cultured cortical neurons for 3 hr before exchanging culture media with fresh media.
GluA1 Surface Staining
Cell surface AMPA receptor labeling was performed as described (Shepherd et al., 2006) . Briefly, after treatment with TTX (1 mM) or bicuculline (20 mM) for 48 hr, cultured neurons on coverslips were incubated with anti-GluA1 antibody in culture medium at 10 C for 20 min. Next, they were washed briefly with fresh culture medium and fixed with a solution containing 4% paraformaldehyde and 4% sucrose in PBS. Cultured neurons were subsequently incubated with Alexa Fluor-conjugated secondary antibodies for the visualization of GluA1. To visualize GFP-transfected neurons, cultures were incubated with 0.1% triton in PBS for 5 min at room temperature and subsequently subject to anti-GFP immunostaining.
Image Acquisition and Analysis
Images for GluA1 surface immunolabeling were acquired with a Zeiss LSM 700 laser-scanning confocal microscope. All images in the same experiment were obtained using the same settings. Image analysis was performed using ImageJ software (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, https://imagej.nih.gov/ij/, 1997-2016). For AMPAR surface expression quantification, dendrite areas with GluA1 staining were traced and the mean fluorescence intensity per pixel was measured. 10-15 dendritic segments (20-50 mM) were averaged for each neuron and used for analysis. 35-50 neurons were analyzed for each of the conditions presented (see figure legends for the sample sizes in individual experiments). Background intensity was subtracted by measuring a region lacking dendrites in each image. Raw fluorescence intensity is presented as absolute unit value in Figure S9 . For GFP-transfected neurons, only GFP + dendrites were selected for measurement. For synaptic GluA1 measurements, GluA1 staining colocalized with PSD95 was selected for intensity measurements. HA Npn2 images were acquired with a Zeiss LSM800 with Airyscan. Quantification of HA Npn2 colocalization with pre-and post-synaptic markers was performed using Imaris (Bitplane) with MCC (Mander's Colocalization Coefficient) quantification (Dunn et al., 2011) . For quantification of HA Npn2 spine localization, dendritic spines were traced and measured in Imaris (Bitplane) using FilamentTracer, and colocalization of HA Npn2 with dendritic spines was then quantified.
Cell Surface Biotinylation
Cell surface biotinylation was performed as described (Shepherd et al., 2006) . Cultured cells were washed twice with ice-cold PBS
2+
(1 x PBS, 1mM CaCl 2 , 0.5mM MgCl 2 ) and incubated in PBS 2+ with 1 mg/ml Sulfo-NHS-SS-Biotin (ThermoFisher Scientific) for 30 min at 4 C. Cells were washed with PBS 2+ and unreacted biotin was quenched with 100 mM glycine in PBS 2+ three times and collected in lysis buffer (10 mM Tris.HCl pH8.0, 140 mM NaCl, 1 mM EDTA 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 50 mM NaF, 5 mM sodium pyrophosphate and protease inhibitor cocktail (Sigma)). Cell lysates were centrifuged at 12,000 x g for 15 min at 4 C. Protein concentration was quantified using a BCA protein assay kit (ThermoFisher Scientific). The resulting supernatants were incubated with streptavidin agarose resin (ThermoFisher Scientific) for 2 hr at 4 C to pull down biotinylated proteins. 2X Laemmli sample buffer was used to elute biotinylated cell surface proteins from the resin. Lysate total protein input and surface protein samples were analyzed with polyacrylamide gel electrophoresis and immunoblotting.
Immunohistochemistry Paraffin sections were generated for analysis of Myc Sema3F mice brains. Mice were anesthetized and perfused transcardially with saline, followed by 4% paraformaldehyde in PBS. Brains were dissected and post-fixed in 4% paraformaldehyde for 24 hr at 4 C, then subjected to series of ethanol dehydration steps (50%, 70%, 95%, 100%), followed by xylene clearing. Brains were incubated with paraffin overnight and then embedded in paraffin. Paraffin-embedded tissue was sectioned using a Leica microtone at a 5-mm thickness. For staining, paraffin sections were gradually rehydrated and subjected to antigen retrieval (incubation at 95 C in 10 mM sodium citrate buffer, pH6.0, for 20 min) before applying primary antibodies (rabbit Myc, rat Ctip2, mouse CaMKII), followed by using corresponding fluorescent-conjugated secondary antibodies to visualize various antigens.
Immunoprecipitation
Cultured cells: cells were lysed in lysis buffer (1 X PBS, pH 7.4 with 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate, 1% Triton X-100, 1 mM PMSF, 50 mM NaF, 5 mM sodium pyrophosphate and protease inhibitor cocktail). 0.5 to 2 mg of antibody was added to the lysates and samples were incubated with rotation at 4 C overnight. Next, samples were incubated with protein A/G agarose resin (ThermoFisher Scientific) with rotation for 2 hr. Resin was washed 5 times with lysis buffer. Proteins were eluted from resin with 2 X Laemmli sample buffer and samples were then subjected to SDS-PAGE and analyzed by western blot.
Brain lysates: brains were homogenized in 10 volumes of ice-cold homogenization buffer (0.32 M sucrose, 10mM HEPES pH7.4, 2 mM EDTA, protease and phosphatase inhibitors) and centrifuged at 1000 x g for 15 min at 4 C. Supernatant (S1) from the previous spin was centrifuged at 200,000 x g to yield crude membrane fraction (P2). 250 mg of the solubilized P2 fraction were mixed with 0.5 to 2 mg the indicated antibodies and then samples were incubated overnight at 4 C before protein A/G agarose resin were added. Samples were incubated with the resin for 2 hr at 4 C. The resin was washed 3 times with high-salt lysis buffer (lysis buffer with 500 mM NaCl) and twice with lysis buffer. Proteins were eluted with 2 X Laemmli sample buffer and the samples were subjected to SDS-PAGE and analyzed by western blot.
Secreted Sema3F Analysis
To detect secreted Myc Sema3F protein in cultured medium, 14 DIV primary cortical cultures derived from E14.5 Myc/Myc Sema3F embryos were treated with TTX or bicuculline for 48 hr. Culture supernatants were collected and subjected to rabbit-anti-Myc immunoprecipitation and analyzed by western blot with a mouse antibody directed against Myc. To detect secreted Sema3F from wildtype cortical cultures, 14 DIV wild-type primary cortical neurons were treated with TTX or bicuculline for 48 hr. Supernatants were centrifuged, collected, filtered, and loaded into a slot-blot apparatus (Bio-Rad). The resulting membranes were incubated with AP-Npn-2 Ecto (5 nM), for 1 hr at room temperature. NBT/BCIP was used as a substrate to detect the presence of the alkaline phosphatase signal. An analogous approach was used to detect Sema3A.
Western Blotting and Quantification
Protein samples were mixed with 2X Laemmli sample buffer and boiled at 95 C for 5 min. Samples were loaded on 4%-20% gradient tris-glycine gels (Bio-Rad). The proteins were transferred to Immobilon-P PVDF membrane (EMD Millipore). After blocking with 5% non-fat milk in TBS-T (TBS containing Tween-20), membranes were incubated with primary antibody overnight, at 4 C. The next day, they were washed three times with TBS-T and membranes were subsequently incubated with HRP-conjugated secondary antibodies. Clarity ECL (Bio-Rad) was applied according to manufacturer's recommendation for signal detection. All western blots shown in the figures are representative images acquired after a single exposure. Multiple exposures were carried out to ensure that signals were within the linear range of detection. Quantification of western blots was carried out using the gel analysis function in ImageJ. Raw quantification of these data are presented in absolute units in Figure S10 . Surface GluA1 levels were measured and normalized to the total GluA1 levels, and the final values for comparison were quantified relative to the untreated wild-type control sample normalized surface GluA1 levels.
Plasmids
Mouse Npn-2 cDNA was cloned into a pCAGGS-IRES-EGFP vector with an N-terminal FLAG tag. Npn-1 or Npn-2 deletion or mutation plasmids were generated using either QuickChange site-directed mutagenesis (Agilent) or In-Fusion HD (Clontech). Npn-1 or Npn-2 deletion or mutation plasmids: Npn-2DCUB1 (C28-K143), Npn-2DCUB2 (C149-I267), Npn-2DCUBs (C28-I267), Npn-2DFV (Q276-C592), Npn-2DMAM (P641-E802), Npn-2 Sema3F-(Npn-2 Q47E, D49A, H52A, Q53R, N54D, H81E), Npn-1 Npn-2CUBs (Npn-1 F22-Q266 replaced with Npn-2 Q23-P272), Npn-2 Npn-1CUB2 (Npn-2 K143-N274 replaced with Npn-1 K142-D273). All clones were sequenced and the expression of correct-sized proteins was confirmed using western blot. Short-hairpin RNA constructs were generated in pLLX vector (generous gift from M. Greenberg). The primer sequences used for constructing pLLX shRNA are: 5 0 -T AGATTGTCCTCAACTTCAA -3 0 (Forward), 5 0 -TCGAG TTCC AAAAAA AGATTGTCCTCAACTTCAA -3 0 (reverse). Empty pLLX vector was used as control. PlexA3 AA was generated by site-directed mutagenesis by replacing two arginine residues (R), R1407 and R1408 with alanines (A), similar to key residues of the RasGAP domain in PlexA1 and PlexA2 (Duan et al., 2014) .
Ligand production and Binding Assay
Alakaline phosphatase (AP)-tagged Sema3A and Sema3F ligands were produced in 293T cells. AP-tagged Sema3A or Sema3F plasmids were transfected into 293T cells. The resulting supernatant was collected and concentrated using Centricon filters (Millipore). Alkaline phosphatase activity was measured by the change in absorbance at OD 405 nm. AP-containing supernatant was mixed with 2X AP substrate buffer (15 mL of diethanolamine, pH9.8 containing 100 mg of p-nitrophenyl phosphate, 15 mL of 1 M MgCl2) and adsorbance of the resulting mixture was determined using a spectrophotometer. For binding assays, COS7 cells were transfected with indicated plasmids. After incubating with the designated ligand, cells were washed with cold HBAH (Hank's balanced salt solution, 0.5 mg/ml BSA, 0.1% NaN3, 20 mM HEPES, pH 7.0) and fixed with acetone-formalin fixative. NBT/BCIP was used to detect AP binding in situ on the cell surface (Tran et al., 2009) .
Electrophysiology
To examine the function of Npn-2 in synaptic scaling, whole cell recordings of spontaneous AMPAR-mediated mEPSCs were performed on cultured cortical neurons derived from E18 wild-type or Npn-2 À/À mouse embryos on 16-17 DIV, 48 hr after a 20 mM bicuculline treatment. Neurons were perfused in HEPES-buffered extracellular solution (143mM NaCl, 5mM KCl, 2mM CaCl 2 , 1mM MgCl 2 , 10mM HEPES, 10mM glucose, pH 7.2, osmolality 305-310 mOsm) in the presence of 1 mM TTX, 100 mM picrotoxin and 100 mM APV. Recording pipettes (3-6 MOhm) were filled with internal solution (115mM Cs-MeSO 4 , 0.4mM EGTA, 5mM TEA-Cl, 2.8mM NaCl, 20mM HEPES, 3mM Mg-ATP, 0.5mM Na 2 -GTP, pH 7.2, osmolality 295-300 mOsm). Neurons were held at À70mV holding potential and recordings were performed at room temperature. Upon entering whole cell mode, we allowed approximately 3 min for dialysis of the intracellular solution before collecting data. Signals were measured with a MultiClamp 700B amplifier and digitized using a Digidata 1440A digitizer (Molecular Devices). Data acquisition was performed with pClamp 10.2 software and digitized at 20kHz. mEPSCs were analyzed semi-automatically with MiniAnalysis (Synaptosoft) using a detection threshold of 7 pA (> 2 times root mean square noise), and were binned at 1pA amplitude or 100ms inter-event interval for comparison. Data were collected from 5 independent cultures and were presented as mean ± SEM.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using Prism (GraphPad Software). For all two-sample comparisons, statistical significance between two mean values was determined by unpaired two-tailed Student's t test. Multiple comparisons were performed using either one-way ANOVA or two-way ANOVA with corrections for multiple comparisons test (see figure legends for specifics). For power analysis, G*Power (Faul et al., 2009 ) was used to analyze the sample size. Statistical significance value was set at p < 0.05.
